Personalizing Your Breast Cancer Treatment Through Genomics

Genomics Genetics

The Oncotype DX breast cancer test is based on genomic science. While genomics and genetics may sound similar, and are indeed related, they focus on different information.

Genetics can help to tell you your risk for getting cancer, while genomics can help once you have cancer to choose your course of care.


Genetics 

Genomics 

Study of inherited traits, such as hair or eye color, that are passed from one generation to the next through genes. Study of the activity and interaction of certain genes in the body, including their role in certain diseases.
Your risk for certain cancers can be inherited, or passed through your genes. Once you have cancer, the activity and interaction of certain genes in your tumor tissue influences the behavior of your tumor, including how likely it is to grow and spread.
The test for the BRCA1 and BRCA2 genes is a genetic test that can help to predict your risk for getting breast or ovarian cancer. The Oncotype DX breast cancer test is a genomic test that can help to predict the aggressiveness of your tumor and whether or not you will benefit from chemotherapy.
Once you know your genetic risk for cancer, you can take steps to lower that risk, such as making lifestyle changes. Once you have the personalized information from your Oncotype DX breast cancer test, you and your doctor can decide what kind of treatment you might need following surgery.